Southern Research Received $8 Million NIH Grant
The funding will establish a new biomedical facility in Birmingham focused on reducing reliance on animal testing.
Updated on Oct. 13, 2026 in Life Sciences
Live Poll
Do you believe replacing animal testing with human-relevant models improves the drug development process?
Southern Research has secured an $8 million grant from the National Institutes of Health to build a specialized biomedical center. The new facility, located in Birmingham, will aim to replace animal testing with human-relevant drug discovery models.
Why it matters
The project seeks to accelerate drug development by creating more accurate models of human biology. By prioritizing human-relevant data, researchers hope to improve the success rate and efficiency of clinical trials.
The grant funds a facility called the Translational Hub for Research, Innovation, Validation, and Excellence. It utilizes laboratory, computational, and data-oriented methods to benchmark new approach methodologies.
The players
Southern Research
This is a non-profit organization based in Birmingham that conducts scientific and medical research.
National Institutes of Health
This is the primary agency of the United States government responsible for biomedical and public health research.
The details
The facility will provide shared access to NIH investigators, government researchers, and pharmaceutical companies to collaborate on drug development. It aims to integrate advanced analytics and human-relevant models to refine the precision of medical research.
Timeline
October 13, 2026: Announcement of the grant and facility.
The Big Picture
The facility follows a pattern set by the National Institutes of Health's alternative methods research program to modernize preclinical drug testing. This development marks a transition toward reliance on human-based data models rather than traditional animal studies.
The facility aims to deliver more effective pharmaceutical treatments by improving the reliability of drug testing protocols. This could eventually lead to safer medications and more efficient medical breakthroughs available to the general public.
The takeaway
This grant highlights a growing scientific effort to align drug development with human-specific biological data. Residents can monitor how these local research advancements contribute to broader changes in international pharmaceutical standards.
Further reading
Learn more about the latest research at the Life Sciences hub.
Source note: This article includes information reported by Pharmaceutical Technology.
Live Poll
Do you believe replacing animal testing with human-relevant models improves the drug development process?
